EPISODE · Jul 11, 2016 · 9 MIN
1q Gain, a Prognostic Biomarker in Nephroblastoma, and What's Next?
from Journal of Clinical Oncology (JCO) Podcast · host Birgit Geoerger
This podcast comments on two independent pediatric studies on both sides of the Atlantic showing the relevance of 1q gain in poor prognosis Wilms tumors which raises the perspectives for therapeutic modifications.
Embed this episode
NOW PLAYING
1q Gain, a Prognostic Biomarker in Nephroblastoma, and What's Next?
0:00
9:02
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Journal of Clinical Oncology (JCO) Podcast?
This episode is 9 minutes long.
When was this Journal of Clinical Oncology (JCO) Podcast episode published?
This episode was published on July 11, 2016.
Can I download this Journal of Clinical Oncology (JCO) Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!